It's a "Meeting of the Minds" at the Fox Chase Cancer Center Science Festival
PHILADELPHIA (June 2, 1999) -- The best and brightest scientists from the Philadelphia region will converge in Northeast Philadelphia for the 4th Annual Fox Chase Cancer Center Post-doc Festival to be held Friday, June 4th from 8 am to 5pm at the Center.
The event promotes collaborations between institutions and pushes discovery in cancer research forward. In addition, the event is designed to provide post-docs with information that will facilitate their transition from trainee to independent scientist.
Those attending the Festival range from undergraduates through post-doctoral fellows ready to initiate job searches. The attendees will represent Fox Chase, University of Pennsylvania, Lehigh University, Princeton University, and Thomas Jefferson University.
The keynote speaker for the Festival is Sydney Brenner, President and Director of Research at Molecular Sciences Institute in Berkely, Ca. The subject of his talk is comparative genetics. It begins at 1:15pm in the Center Auditorium.
Some of the proceeds from the event will support the construction of the Fox Chase Cancer Prevention Pavilion, the first such institute anywhere in the world. The Prevention Pavilion will house research focused on developing methods of early detection of cancer, increasing the monitoring of populations determined to be at risk of the disease, and decreasing of risk of cancer through behavior modification.
Fox Chase Cancer Center is one of 35 National Cancer Institute-designated comprehensive cancer centers in the nation. The Center's activities include basic and clinical research, prevention, detection and treatment of cancer and community outreach programs.
Schedule of Events
|9:10am||Postdoctoral Research Presentations (oral)|
|1:15pm||KEYNOTE PRESENTATION - "Comparative Genetics," by Sydney Brenner, President and Director of Research, Molecular Sciences Institute|
|3:30pm||Panel Discussion - "Employment opportunities in the biotech industry." Representatives from: Jannsen Pharmaceuticals; Cephalon; Small Molecule Therapeutics; Merck; Bristol-Myers Squibb Company|
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.